24
Views
73
CrossRef citations to date
0
Altmetric
Cell Growth and Development

DNA Damage Is a Prerequisite for p53-Mediated Proteasomal Degradation of HIF-1α in Hypoxic Cells and Downregulation of the Hypoxia Marker Carbonic Anhydrase IX

, , &
Pages 5757-5766 | Received 09 Dec 2003, Accepted 08 Apr 2004, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Rana Ghandehari-Alavijeh, Dina Zohrabi, Marziyeh Tavalaee & Mohammad Hossein Nasr-Esfahani. (2019) Association between expression of TNF-α, P53 and HIF1α with asthenozoospermia. Human Fertility 22:2, pages 145-151.
Read now
Jun Yang, Afshan Ahmed, Evon Poon, Nina Perusinghe, Alexis de Haven Brandon, Gary Box, Melanie Valenti, Suzanne Eccles, Kasper Rouschop, Brad Wouters & Margaret Ashcroft. (2009) Small-Molecule Activation of p53 Blocks Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor Expression In Vivo and Leads to Tumor Cell Apoptosis in Normoxia and Hypoxia. Molecular and Cellular Biology 29:8, pages 2243-2253.
Read now
Ying Li, Hai Wang, Egbert Oosterwijk, Chingkuang Tu, Kathleen T. Shiverick, David N. Silverman & Susan C. Frost. (2009) Expression and Activity of Carbonic Anhydrase IX Is Associated With Metabolic Dysfunction in MDA-MB-231 Breast Cancer Cells. Cancer Investigation 27:6, pages 613-623.
Read now
Stefan Kaluz, Milota Kaluzová & Eric J. Stanbridge. (2006) Proteasomal Inhibition Attenuates Transcriptional Activity of Hypoxia-Inducible Factor 1 (HIF-1) via Specific Effect on the HIF-1α C-Terminal Activation Domain. Molecular and Cellular Biology 26:15, pages 5895-5907.
Read now

Articles from other publishers (69)

Mengdi Qin, Qiang Liu, Wei Yang, Qiaofeng Wang & Zheng Xiang. (2022) IGFL2‐AS1 ‐induced suppression of HIF ‐1α degradation promotes cell proliferation and invasion in colorectal cancer by upregulating CA9 . Cancer Medicine 12:7, pages 8415-8432.
Crossref
Alessandro Pietro Aldera & Dhirendra Govender. (2021) Carbonic anhydrase IX: a regulator of pH and participant in carcinogenesis. Journal of Clinical Pathology 74:6, pages 350-354.
Crossref
Hatice Pilevneli & Mehtap Kilic-Eren. (2021) Targeting oncogenic WIP1 phosphatase sensitizes hypoxic breast cancer cells to doxorubicin induced apoptosis via activation of p53-p21 axis. Gene Reports 23, pages 101144.
Crossref
Uldouz Kharazi & Reza Badalzadeh. (2020) A review on the stem cell therapy and an introduction to exosomes as a new tool in reproductive medicine. Reproductive Biology 20:4, pages 447-459.
Crossref
Ji Ye Lim, Chun Liu, Kang‐Quan Hu, Donald E. Smith, Dayong Wu, Stefania Lamon‐Fava, Lynne M. Ausman & Xiang‐Dong Wang. (2020) Xanthophyll β‐Cryptoxanthin Inhibits Highly Refined Carbohydrate Diet–Promoted Hepatocellular Carcinoma Progression in Mice. Molecular Nutrition & Food Research 64:3, pages 1900949.
Crossref
Tomas Koltai, Stephan J. Reshkin & Salvador Harguindey. 2020. An Innovative Approach to Understanding and Treating Cancer: Targeting pH. An Innovative Approach to Understanding and Treating Cancer: Targeting pH 157 176 .
Zahra Ghanbari Movahed, Mohsen Rastegari-Pouyani, Mohammad hossein Mohammadi & Kamran Mansouri. (2019) Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?. Biomedicine & Pharmacotherapy 112, pages 108690.
Crossref
Ivano AmelioMara Mancini, Varvara PetrovaRob A. CairnsPolina VikhrevaSara NicolaiAlberto MariniAlexey A. AntonovJohn Le QuesneJuvenal D. Baena AcevedoKate DudekGabriella SozziUgo PastorinoRichard A. KnightTak W. MakGerry Melino. (2018) p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression. Proceedings of the National Academy of Sciences 115:46.
Crossref
Ana Sara Gomes, Helena Ramos, Joana Soares & Lucília Saraiva. (2018) p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Pharmacological Research 131, pages 75-86.
Crossref
Xiang Zou, Li Zhang, Jie Yuan, Chunjie Yang, Zehan Wu, Jianping Song, Wei Zhu, Ying Mao & Liang Chen. (2017) Endogenous hormone 2-methoxyestradiol suppresses venous hypertension-induced angiogenesis through up- and down-regulating p53 and id-1. Journal of Cellular and Molecular Medicine.
Crossref
Mariko Okamoto, Ai Asamura, Ko Tanaka, Takefumi Soeda, Kyo Watanabe, Hiroyuki Mizuguchi & Teruo Ikeda. (2016) Expression of HIF-1α ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia. Veterinary Research Communications 40:3-4, pages 131-139.
Crossref
Guang Chen, Jin-Ye Xu, Jie Chen, Jian-Xin Zhang, Jun Zhou, Yong Liang & Xiao-Fei Ding. (2016) Loss of PIG3 increases HIF-1α level by promoting protein synthesis via mTOR pathway in renal cell carcinoma cells . Oncotarget 7:19, pages 27176-27184.
Crossref
B. Woodby, M. Scott & J. Bodily. 2016. Molecular and Cellular Changes in the Cancer Cell. Molecular and Cellular Changes in the Cancer Cell 169 238 .
M. Liang, J. Wen, Q. Dong, L.-G. Zhao & B.-K. Shi. (2015) Testicular hypofunction caused by activating p53 expression induced by reactive oxygen species in varicocele rats. Andrologia 47:10, pages 1175-1182.
Crossref
Ivano Amelio & Gerry Melino. (2015) The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression. Trends in Biochemical Sciences 40:8, pages 425-434.
Crossref
MICHAL PASTOREK, VERONIKA SIMKO, MARTINA TAKACOVA, MONIKA BARATHOVA, MARIA BARTOSOVA, LUBA HUNAKOVA, OLGA SEDLAKOVA, SONA HUDECOVA, OLGA KRIZANOVA, FRANCK DEQUIEDT, SILVIA PASTOREKOVA & JAN SEDLAK. (2015) Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy. International Journal of Oncology 47:1, pages 51-60.
Crossref
Guanqiao Wang, Zhenguo Cheng, Funan Liu, Hongyan Zhang, Jiabin Li & Feng Li. (2015) CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer. Cellular Signalling 27:7, pages 1369-1379.
Crossref
Adam Kinnaird & Evangelos D. Michelakis. (2015) Metabolic modulation of cancer: a new frontier with great translational potential. Journal of Molecular Medicine 93:2, pages 127-142.
Crossref
N Bigot, C Guérillon, S Loisel, N Bertheuil, L Sensebé, K Tarte & R Pedeux. (2015) ING1b negatively regulates HIF1α protein levels in adipose-derived stromal cells by a SUMOylation-dependent mechanism. Cell Death & Disease 6:1, pages e1612-e1612.
Crossref
Tai-Cheng Hou, Ying-Yi Wu, Po-Yi Chiang & Kui-Thong Tan. (2015) Near-infrared fluorescence activation probes based on disassembly-induced emission cyanine dye. Chemical Science 6:8, pages 4643-4649.
Crossref
Elena Ondriskova, Michaela Debreova & Silvia Pastorekova. 2015. Carbonic Anhydrases as Biocatalysts. Carbonic Anhydrases as Biocatalysts 169 205 .
Khaled Ghattass, Sally El-Sitt, Kazem Zibara, Saide Rayes, Makhluf J Haddadin, Marwan El-Sabban & Hala Gali-Muhtasib. (2014) The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway. Molecular Cancer 13:1.
Crossref
Xiaoxi Han, Shengkun Sun, Ming Zhao, Xiang Cheng, Guozhu Chen, Song Lin, Yifu Guan & Xiaodan Yu. (2014) Celastrol Stimulates Hypoxia-Inducible Factor-1 Activity in Tumor Cells by Initiating the ROS/Akt/p70S6K Signaling Pathway and Enhancing Hypoxia-Inducible Factor-1α Protein Synthesis. PLoS ONE 9:11, pages e112470.
Crossref
Jun-Ho Jang, Shannon Bruse, Salam Huneidi, Ronald M. Schrader, Martha M. Monick, Yong Lin, A. Brent Carter, Aloysius J. Klingelhutz & Toru Nyunoya. (2014) Acrolein-Exposed Normal Human Lung Fibroblasts in Vitro : Cellular Senescence, Enhanced Telomere Erosion, and Degradation of Werner’s Syndrome Protein . Environmental Health Perspectives 122:9, pages 955-962.
Crossref
Narges K. Tafreshi, Mark C. Lloyd, Marilyn M. Bui, Robert J. Gillies & David L. Morse. 2014. Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications. Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications 221 254 .
Joanna Obacz, Silvia Pastorekova, Borek Vojtesek & Roman Hrstka. (2013) Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses. Molecular Cancer 12:1.
Crossref
Gopinath Sutendra, Peter Dromparis, Roxane Paulin, Sotirios Zervopoulos, Alois Haromy, Jayan Nagendran & Evangelos D. Michelakis. (2013) A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. Journal of Molecular Medicine 91:11, pages 1315-1327.
Crossref
Yimiao Xu, Ying Diao, Shimei Qi, Xiaolong Pan, Qi Wang, Yinqiang Xin, Xiang Cao, Jie Ruan, Zhihui Zhao, Lan Luo, Chang Liu & Zhimin Yin. (2013) Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis. Cellular Signalling 25:5, pages 1176-1185.
Crossref
G Sutendra, P Dromparis, A Kinnaird, T H Stenson, A Haromy, J M R Parker, M S McMurtry & E D Michelakis. (2012) Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer. Oncogene 32:13, pages 1638-1650.
Crossref
Peter DromparisEvangelos D. Michelakis. (2013) Mitochondria in Vascular Health and Disease. Annual Review of Physiology 75:1, pages 95-126.
Crossref
Corine Bertolotto. (2013) Melanoma: From Melanocyte to Genetic Alterations and Clinical Options. Scientifica 2013, pages 1-22.
Crossref
Karen J. Lefebvre, Sarah Assadian, Wissal El-Assaad & Jose G. Teodoro. 2013. Experimental and Clinical Metastasis. Experimental and Clinical Metastasis 79 99 .
J de Lange, L V Ly, K Lodder, M Verlaan-de Vries, A F A S Teunisse, M J Jager & A G Jochemsen. (2011) Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma. Oncogene 31:9, pages 1105-1116.
Crossref
Paul C. McDonald, Jean-Yves Winum, Claudiu T. Supuran & Shoukat Dedhar. (2012) Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics. Oncotarget 3:1, pages 84-97.
Crossref
Kensuke KojimaTeresa McQueenYe ChenRodrigo JacamoMarina KonoplevaNaoki ShinojimaElizabeth Shpall, Xuelin Huang & Michael Andreeff. (2011) p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α–mediated down-regulation of CXCL12. Blood 118:16, pages 4431-4439.
Crossref
Yng-Miin Toh & Tsai-Kun Li. (2011) Mitoxantrone Inhibits HIF-1α Expression in a Topoisomerase II–Independent Pathway. Clinical Cancer Research 17:15, pages 5026-5037.
Crossref
Liying Wang, Sudjit Luanpitpong, Vincent Castranova, William Tse, Yongju Lu, Varisa Pongrakhananon & Yon Rojanasakul. (2011) Carbon Nanotubes Induce Malignant Transformation and Tumorigenesis of Human Lung Epithelial Cells. Nano Letters 11:7, pages 2796-2803.
Crossref
A Sermeus & C Michiels. (2011) Reciprocal influence of the p53 and the hypoxic pathways. Cell Death & Disease 2:5, pages e164-e164.
Crossref
A Ahmed, J Yang, A Maya-Mendoza, D A Jackson & M Ashcroft. (2011) Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1. Cell Death & Disease 2:5, pages e160-e160.
Crossref
Jason M. Bodily, Kavi P.M. Mehta & Laimonis A. Laimins. (2011) Human Papillomavirus E7 Enhances Hypoxia-Inducible Factor 1–Mediated Transcription by Inhibiting Binding of Histone Deacetylases. Cancer Research 71:3, pages 1187-1195.
Crossref
M. R. Fernandez-Fernandez & B. Sot. (2010) The relevance of protein-protein interactions for p53 function: the CPE contribution. Protein Engineering Design and Selection 24:1-2, pages 41-51.
Crossref
Kyeong Lee, Jung Eun Kang, Song-Kyu Park, Yinglan Jin, Kyung-Sook Chung, Hwan-Mook Kim, Kiho Lee, Moo Rim Kang, Myung Kyu Lee, Kyung Bin Song, Eun-Gyeong Yang, Jung-Jun Lee & Misun Won. (2010) LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line. Biochemical Pharmacology 80:7, pages 982-989.
Crossref
Lorenzo Montanaro, Maria Calienni, Sara Bertoni, Laura Rocchi, Pasquale Sansone, Gianluca Storci, Donatella Santini, Claudio Ceccarelli, Mario Taffurelli, Domenica Carnicelli, Maurizio Brigotti, Massimiliano Bonafè, Davide Treré & Massimo Derenzini. (2010) Novel Dyskerin-Mediated Mechanism of p53 Inactivation through Defective mRNA Translation. Cancer Research 70:11, pages 4767-4777.
Crossref
Jessica Jie Wei Lou, Yee Liu Chua, Eng Hui Chew, Jie Gao, Martin Bushell & Thilo Hagen. (2010) Inhibition of Hypoxia-Inducible Factor-1α (HIF-1α) Protein Synthesis by DNA Damage Inducing Agents. PLoS ONE 5:5, pages e10522.
Crossref
Yangguang Shao, Yan Li, Jian Zhang, Di Liu, Furong Liu, Yue Zhao, Tao Shen & Feng Li. (2010) Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX. Nucleic Acids Research 38:9, pages 2813-2824.
Crossref
Johanna Chiche, M. Christiane Brahimi-Horn & Jacques Pouysségur. (2010) Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. Journal of Cellular and Molecular Medicine 14:4, pages 771-794.
Crossref
Jorge L. Ruas, Utta Berchner-Pfannschmidt, Sohail Malik, Katarina Gradin, Joachim Fandrey, Robert G. Roeder, Teresa Pereira & Lorenz Poellinger. (2010) Complex Regulation of the Transactivation Function of Hypoxia-inducible Factor-1α by Direct Interaction with Two Distinct Domains of the CREB-binding Protein/p300. Journal of Biological Chemistry 285:4, pages 2601-2609.
Crossref
Jose G. Teodoro, Sara K. Evans & Michael R. Green. 2010. Cancer Genome and Tumor Microenvironment. Cancer Genome and Tumor Microenvironment 189 216 .
Vered Daniel-Carmi, Efrat Makovitzki-Avraham, Eliran-Moshe Reuven, Ido Goldstein, Noga Zilkha, Varda Rotter, Esther Tzehoval & Lea Eisenbach. (2009) The human 1-8D gene ( IFITM2 ) is a novel p53 independent pro-apoptotic gene . International Journal of Cancer 125:12, pages 2810-2819.
Crossref
Stefan Kaluz, Milota Kaluzová, Shu-Yuan Liao, Michael Lerman & Eric J. Stanbridge. (2009) Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1795:2, pages 162-172.
Crossref
Shengxiang Dong, Gang Huang, Penan Liu, Yubo Ma, Weili Yan, Liangrong Wan & Changqing Zhu. (2009) Efficacy and safety of 32P-nanocolloid for treatment of distant lymph node metastasis in VX2 tumor-bearing rabbits. Annals of Nuclear Medicine 22:10, pages 849-858.
Crossref
Stefan Kaluz, Milota Kaluzová & Eric J. Stanbridge. (2008) Regulation of gene expression by hypoxia: Integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clinica Chimica Acta 395:1-2, pages 6-13.
Crossref
J Hao, X Song, B Song, Y Liu, L Wei, X Wang & J Yu. (2008) Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells. Cancer Gene Therapy 15:7, pages 449-455.
Crossref
Shuhong Guo, Olga Bragina, Yuexian Xu, Zongxian Cao, Hu Chen, Bo Zhou, Marilee Morgan, Yong Lin, Bing-Hua Jiang, Ke Jian Liu & Honglian Shi. (2008) Glucose up-regulates HIF-1α expression in primary cortical neurons in response to hypoxia through maintaining cellular redox status. Journal of Neurochemistry 105:5, pages 1849-1860.
Crossref
Stefan Kaluz, Milota Kaluzová & Eric J. Stanbridge. (2008) Rational design of minimal hypoxia-inducible enhancers. Biochemical and Biophysical Research Communications 370:4, pages 613-618.
Crossref
Constantina Constantinou, Androulla Elia & Michael J. Clemens. (2008) Activation of p53 stimulates proteasome-dependent truncation of eIF4E-binding protein 1 (4E-BP1). Biology of the Cell 100:5, pages 279-289.
Crossref
Jose G. Teodoro, Sara K. Evans & Michael R. Green. (2007) Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. Journal of Molecular Medicine 85:11, pages 1175-1186.
Crossref
Monique C.A. Duyndam, Maria P.A. van Berkel, Josephine C. Dorsman, Davy A.P. Rockx, Herbert M. Pinedo & Epie Boven. (2007) Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells. Biochemical Pharmacology 74:2, pages 191-201.
Crossref
H-L Sun, Y-N Liu, Y-T Huang, S-L Pan, D-Y Huang, J-H Guh, F-Y Lee, S-C Kuo & C-M Teng. (2007) YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia. Oncogene 26:27, pages 3941-3951.
Crossref
David A. Rempe, Katherine M. Lelli, Grace Vangeison, Randall S. Johnson & Howard J. Federoff. (2007) In Cultured Astrocytes, p53 and MDM2 Do Not Alter Hypoxia-inducible Factor-1α Function Regardless of the Presence of DNA Damage. Journal of Biological Chemistry 282:22, pages 16187-16201.
Crossref
Hamid Reza Rezvani, Sophie Dedieu, Sophie North, Francis Belloc, Rodrigue Rossignol, Thierry Letellier, Hubert de Verneuil, Alain Taïeb & Frédéric Mazurier. (2007) Hypoxia-inducible Factor-1α, a Key Factor in the Keratinocyte Response to UVB Exposure. Journal of Biological Chemistry 282:22, pages 16413-16422.
Crossref
P Sansone, G Storci, S Pandolfi, L Montanaro, P Chieco & M Bonafé. (2007) The p53 codon 72 proline allele is endowed with enhanced cell-death inducing potential in cancer cells exposed to hypoxia. British Journal of Cancer 96:8, pages 1302-1308.
Crossref
Mark Creighton-Gutteridge, John H. CardellinaIIII, Andrew G. Stephen, Annamaria Rapisarda, Badarch Uranchimeg, Karen Hite, William A. Denny, Robert H. Shoemaker & Giovanni Melillo. (2007) Cell Type–Specific, Topoisomerase II–Dependent Inhibition of Hypoxia-Inducible Factor-1α Protein Accumulation by NSC 644221. Clinical Cancer Research 13:3, pages 1010-1018.
Crossref
Leon P. Oehlers, Amy N. Perez & Ronald B. Walter. (2007) Detection of hypoxia-related proteins in medaka (Oryzias latipes) brain tissue by difference gel electrophoresis and de novo sequencing of 4-sulfophenyl isothiocyanate-derivatized peptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 145:1, pages 120-133.
Crossref
Antoine Hubert, Sébastien Paris, Jean-Pascal Piret, Noëlle Ninane, Martine Raes & Carine Michiels. (2006) Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level. Journal of Cell Science 119:16, pages 3351-3362.
Crossref
Donna M. Fath, Xianguo Kong, Dongming Liang, Zhao Lin, Andrew Chou, Yubao Jiang, Jie Fang, Jaime Caro & Nianli Sang. (2006) Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-inducible Factors Independently of Direct Acetylation of HIF-α. Journal of Biological Chemistry 281:19, pages 13612-13619.
Crossref
Silvia Pastorekova, Seppo Parkkila & Jan Zavada. 2006. 167 216 .
Julia I. Bárdos & Margaret Ashcroft. (2005) Negative and positive regulation of HIF-1: A complex network. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1755:2, pages 107-120.
Crossref
Tobias Schmid, Jie Zhou & Bernhard Brüne. (2004) HIF-1 and p53: communication of transcription factors under hypoxia. Journal of Cellular and Molecular Medicine 8:4, pages 423-431.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.